Found: 46
Select item for more details and to access through your institution.
3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia.
- Published in:
- International Journal of Neuropsychopharmacology, 2011, v. 14, n. 6, p. 756, doi. 10.1017/S1461145710001689
- By:
- Publication type:
- Article
EARLY AND EFFECTIVE TREATMENT OF SCHIZOPHRENIA.
- Published in:
- Psychiatric Times, 2008, v. 25, p. 9
- By:
- Publication type:
- Article
S79. HEALTH STATUS OF PREMENOPAUSAL WOMEN WITH SCHIZOPHRENIA HAVING HYPERPROLACTINEMIA.
- Published in:
- Schizophrenia Bulletin, 2019, v. 45, p. S337, doi. 10.1093/schbul/sbz020.624
- By:
- Publication type:
- Article
T85. THE EFFECT OF ADJUNCT ARIPIPRAZOLE ON MEASURES OF TOBACCO USE AND CRAVING IN WOMEN WITH PSYCHOTIC DISORDERS.
- Published in:
- Schizophrenia Bulletin, 2019, v. 45, p. S236, doi. 10.1093/schbul/sbz019.365
- By:
- Publication type:
- Article
F88. CHILDHOOD SEXUAL ABUSE AND ADULT SEXUAL BEHAVIOR IN WOMEN WITH ANTIPSYCHOTIC-INDUCED HYPERPROLACTINEMIA.
- Published in:
- Schizophrenia Bulletin, 2019, v. 45, p. S287, doi. 10.1093/schbul/sbz018.500
- By:
- Publication type:
- Article
Principal Components of Heritability From Neurocognitive Domains Differ Between Families With Schizophrenia and Control Subjects.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Principal Components of Heritability From Neurocognitive Domains Differ Between Families With Schizophrenia and Control Subjects.
- Published in:
- Schizophrenia Bulletin, 2013, v. 39, n. 2, p. 464, doi. 10.1093/schbul/sbr161
- By:
- Publication type:
- Article
Evaluation of HLA Polymorphisms in Relation to Schizophrenia Risk and Infectious Exposure.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Evaluation of HLA Polymorphisms in Relation to Schizophrenia Risk and Infectious Exposure.
- Published in:
- Schizophrenia Bulletin, 2012, v. 38, n. 6, p. 1149, doi. 10.1093/schbul/sbs087
- By:
- Publication type:
- Article
Cross-sectional and Longitudinal Relationships Between Insight and Attitudes Toward Medication and Clinical Outcomes in Chronic Schizophrenia.
- Published in:
- Schizophrenia Bulletin, 2009, v. 35, n. 2, p. 336, doi. 10.1093/schbul/sbn067
- By:
- Publication type:
- Article
Revised PORT Recommendations.
- Published in:
- Schizophrenia Bulletin, 2004, v. 30, n. 3, p. 609, doi. 10.1093/oxfordjournals.schbul.a007106
- By:
- Publication type:
- Article
Assessing Clinical and Functional Outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial.
- Published in:
- Schizophrenia Bulletin, 2003, v. 29, n. 1, p. 33, doi. 10.1093/oxfordjournals.schbul.a006989
- By:
- Publication type:
- Article
The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Project: Schizophrenia Trial Design and Protocol Development.
- Published in:
- Schizophrenia Bulletin, 2003, v. 29, n. 1, p. 15, doi. 10.1093/oxfordjournals.schbul.a006986
- By:
- Publication type:
- Article
Common Sense, Insight, and Neuropsychological Test Performance in Schizophrenia Patients.
- Published in:
- Schizophrenia Bulletin, 1996, v. 22, n. 4, p. 635, doi. 10.1093/schbul/22.4.635
- By:
- Publication type:
- Article
Use of Clozapine in Schizophrenia.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Efficiency of the CATIE and BACS neuropsychological batteries in assessing cognitive effects of antipsychotic treatments in schizophrenia.
- Published in:
- Journal of the International Neuropsychological Society, 2008, v. 14, n. 2, p. 209, doi. 10.1017/S1355617708080570
- By:
- Publication type:
- Article
Impaired insight in schizophrenia: impact on patient-reported and physician-reported outcome measures in a randomized controlled trial.
- Published in:
- BMC Psychiatry, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12888-022-04190-w
- By:
- Publication type:
- Article
Lipidomics Reveals Early Metabolic Changes in Subjects with Schizophrenia: Effects of Atypical Antipsychotics.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0068717
- By:
- Publication type:
- Article
Associations between Purine Metabolites and Clinical Symptoms in Schizophrenia.
- Published in:
- PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0042165
- By:
- Publication type:
- Article
Homeostatic Imbalance of Purine Catabolism in First- Episode Neuroleptic-Naïve Patients with Schizophrenia.
- Published in:
- PLoS ONE, 2010, v. 5, n. 3, p. 1, doi. 10.1371/journal.pone.0009508
- By:
- Publication type:
- Article
A Double-Blind Clinical Trial of Mianserin Versus Amitriptyline: Differentiation by Adverse Symptomatology.
- Published in:
- Pharmacotherapy, 1983, v. 3, n. 1, p. 45, doi. 10.1002/j.1875-9114.1983.tb04532.x
- By:
- Publication type:
- Article
Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia.
- Published in:
- CNS Drugs, 2021, v. 35, n. 11, p. 1189, doi. 10.1007/s40263-021-00861-6
- By:
- Publication type:
- Article
Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis.
- Published in:
- European Journal of Human Genetics, 2009, v. 17, n. 7, p. 946, doi. 10.1038/ejhg.2008.264
- By:
- Publication type:
- Article
Adjunctive Minocycline in Clozapine-Treated Patients with Schizophrenia: Analyzing the Effects of Minocycline on Clozapine Plasma Levels.
- Published in:
- Psychiatric Quarterly, 2018, v. 89, n. 1, p. 73, doi. 10.1007/s11126-017-9515-x
- By:
- Publication type:
- Article
Long-term effect of aripiprazole lauroxil on health-related quality of life in patients with schizophrenia.
- Published in:
- BMC Psychiatry, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12888-021-03124-2
- By:
- Publication type:
- Article
Effects of Davunetide on N-acetylaspartate and Choline in Dorsolateral Prefrontal Cortex in Patients with Schizophrenia.
- Published in:
- Neuropsychopharmacology, 2013, v. 38, n. 7, p. 1245, doi. 10.1038/npp.2013.23
- By:
- Publication type:
- Article
Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia.
- Published in:
- Neuropsychopharmacology, 2011, v. 36, n. 3, p. 616, doi. 10.1038/npp.2010.193
- By:
- Publication type:
- Article
Baseline Neurocognitive Deficits in the CATIE Schizophrenia Trial.
- Published in:
- Neuropsychopharmacology, 2006, v. 31, n. 9, p. 2033, doi. 10.1038/sj.npp.1301072
- By:
- Publication type:
- Article
Nicotine Decreases Bradykinesia-rigidity in Haloperidol-treated Patients with Schizophrenia
- Published in:
- Neuropsychopharmacology, 2002, v. 27, n. 4, p. 684
- By:
- Publication type:
- Article
Monitoring for myocarditis during treatment initiation with clozapine.
- Published in:
- Acta Psychiatrica Scandinavica, 2021, v. 144, n. 2, p. 194, doi. 10.1111/acps.13328
- By:
- Publication type:
- Article
Source monitoring improvement in patients with schizophrenia receiving antipsychotic medications.
- Published in:
- Psychopharmacology, 2003, v. 169, n. 3/4, p. 383, doi. 10.1007/s00213-003-1476-0
- By:
- Publication type:
- Article
Nurturing mental health and well-being using ordinary farms.
- Published in:
- Irish Journal of Occupational Therapy, 2023, v. 51, n. 1, p. 1, doi. 10.1108/IJOT-07-2022-0026
- By:
- Publication type:
- Article
Employment Outcomes in a Randomized Trial of Second-Generation Antipsychotics and Perphenazine in the Treatment of Individuals with Schizophrenia.
- Published in:
- Journal of Behavioral Health Services & Research, 2008, v. 35, n. 2, p. 215, doi. 10.1007/s11414-007-9101-3
- By:
- Publication type:
- Article
First- and Second-Generation Antipsychotics.
- Published in:
- Canadian Journal of Psychiatry, 2010, v. 55, n. 3, p. 144, doi. 10.1177/070674371005500305
- By:
- Publication type:
- Article
Time-Lapse Mapping of Cortical Changes in Schizophrenia with Different Treatments.
- Published in:
- Cerebral Cortex, 2009, v. 19, n. 5, p. 1107
- By:
- Publication type:
- Article
Suicide Reduction in Schizophrenia via Exercise (SUnRISE): study protocol for a multi-site, single-blind, randomized clinical trial of aerobic exercise for suicide risk reduction in individuals with schizophrenia.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A Genome-Wide Investigation of SNPs and CNVs in Schizophrenia.
- Published in:
- PLoS Genetics, 2009, v. 5, n. 2, p. 1, doi. 10.1371/journal.pgen.1000373
- By:
- Publication type:
- Article
Effect of tardive dyskinesia on quality of life in patients with bipolar disorder, major depressive disorder, and schizophrenia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Quantitative levels of aripiprazole parent drug and metabolites in urine.
- Published in:
- Psychopharmacology, 2014, v. 231, n. 23, p. 4421, doi. 10.1007/s00213-014-3781-1
- By:
- Publication type:
- Article
Antipsychotic medications for schizophrenia--reply.
- Published in:
- 2014
- By:
- Publication type:
- commentary
COMMENT & RESPONSE.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
Effectiveness of paliperidone palmitate vs haloperidol decanoate for maintenance treatment of schizophrenia: a randomized clinical trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Effectiveness of Paliperidone Palmitate vs Haloperidol Decanoate for Maintenance Treatment of Schizophrenia.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 311, n. 19, p. 1978, doi. 10.1001/jama.2014.4310
- By:
- Publication type:
- Article
Smoking and schizophrenia.
- Published in:
- Drug Development Research, 1996, v. 38, n. 3/4, p. 263, doi. 10.1002/(SICI)1098-2299(199607/08)38:3/4<263::AID-DDR15>3.0.CO;2-#
- By:
- Publication type:
- Article
A double-blind comparison of abecarnil and diazepam in the treatment of uncomplicated alcohol withdrawal.
- Published in:
- Psychopharmacology, 1997, v. 131, n. 2, p. 123, doi. 10.1007/s002130050274
- By:
- Publication type:
- Article
A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future.
- Published in:
- Neuropsychiatric Disease & Treatment, 2019, v. 15, p. 2559, doi. 10.2147/NDT.S209284
- By:
- Publication type:
- Article